These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34680436)

  • 21. Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.
    Scott CL; Becker MA; Haluska P; Samimi G
    Front Oncol; 2013 Dec; 3():295. PubMed ID: 24363999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
    Landuzzi L; Manara MC; Lollini PL; Scotlandi K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models.
    Chen L; Pan X; Zhang YH; Hu X; Feng K; Huang T; Cai YD
    Front Genet; 2019; 10():738. PubMed ID: 31456818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
    Adnan N; Lei C; Ruan J
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
    Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
    Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
    [No Abstract]   [Full Text] [Related]  

  • 29. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
    El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes.
    Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L
    Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.
    Chen D; Huang X; Cai J; Guo S; Qian W; Wery JP; Li QX
    Oncotarget; 2015 Dec; 6(38):40815-21. PubMed ID: 26512781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
    Bertotti A; Migliardi G; Galimi F; Sassi F; Torti D; Isella C; Corà D; Di Nicolantonio F; Buscarino M; Petti C; Ribero D; Russolillo N; Muratore A; Massucco P; Pisacane A; Molinaro L; Valtorta E; Sartore-Bianchi A; Risio M; Capussotti L; Gambacorta M; Siena S; Medico E; Sapino A; Marsoni S; Comoglio PM; Bardelli A; Trusolino L
    Cancer Discov; 2011 Nov; 1(6):508-23. PubMed ID: 22586653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression.
    Xu H; Lien T; Bergholtz H; Fleischer T; Djerroudi L; Vincent-Salomon A; Sørlie T; Aittokallio T
    Front Genet; 2021; 12():670749. PubMed ID: 34149812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDXliver: a database of liver cancer patient derived xenograft mouse models.
    He S; Hu B; Li C; Lin P; Tang WG; Sun YF; Feng FY; Guo W; Li J; Xu Y; Yao QL; Zhang X; Qiu SJ; Zhou J; Fan J; Li YX; Li H; Yang XR
    BMC Cancer; 2018 May; 18(1):550. PubMed ID: 29743053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin.
    Berthelet J; Foroutan M; Bhuva DD; Whitfield HJ; El-Saafin F; Cursons J; Serrano A; Merdas M; Lim E; Charafe-Jauffret E; Ginestier C; Ernst M; Hollande F; Anderson RL; Pal B; Yeo B; Davis MJ; Merino D
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
    Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
    Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
    Evans KW; Yuca E; Akcakanat A; Scott SM; Arango NP; Zheng X; Chen K; Tapia C; Tarco E; Eterovic AK; Black DM; Litton JK; Yap TA; Tripathy D; Mills GB; Meric-Bernstam F
    Clin Cancer Res; 2017 Nov; 23(21):6468-6477. PubMed ID: 29093017
    [No Abstract]   [Full Text] [Related]  

  • 40. Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.
    Brown KM; Xue A; Julovi SM; Gill AJ; Pavlakis N; Samra JS; Smith RC; Hugh TJ
    J Surg Res; 2018 Jul; 227():158-167. PubMed ID: 29804848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.